...
首页> 外文期刊>Human Molecular Genetics >Frataxin expression rescues mitochondrial dysfunctions in FRDA cells.
【24h】

Frataxin expression rescues mitochondrial dysfunctions in FRDA cells.

机译:Frataxin表达可挽救FRDA细胞中的线粒体功能障碍。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Friedreich's ataxia (FRDA) is the result of mutations in the nuclear-encoded frataxin gene, which is expressed in mitochondria. Several lines of evidence have suggested that frataxin is involved in mitochondrial iron homeostasis. We have transfected the frataxin gene into lymphoblasts of FRDA compound heterozygotes (FRDA-CH) with deficient frataxin expression to produce FRDA-CH-t cells in which message and protein are rescued to near-physiological levels. FRDA-CH cells were more sensitive to oxidative stress by challenge with free iron, hydrogen peroxide and the combination, consistent with a Fenton chemical mechanism of pathophysiology, and this sensitivity was rescued to control levels in FRDA-CH-t cells. Iron challenge caused increased mitochondrial iron levels in FRDA-CH cells, and a decreased mitochondrial membrane potential (MMP), both of which were rescued in FRDA-CH-t cells. The rescue of the low MMP, and high mitochondrial iron concentration by frataxin overexpression suggests that these cellular phenotypes are relevant to the central pathophysiological process in FRDA which is aggravated by exposure to free iron. However, even at physiological iron concentrations, FRDA-CH cells had decreased MMP as well as lower activities of aconitase and ICDH (two enzymes supporting MMP), and twice the level of filtrable mitochondrial iron (but no increase in total mitochondrial iron), and the observed phenotypes were either fully or partially rescued in FRDA-CH-t cells. Free iron is known to be toxic. The observation that frataxin deficiency (either directly or indirectly) causes an increase in filtrable mitochondrial iron provides a new hypothesis for the mechanism of cell death in this disease, and could be a target for therapy.
机译:Friedreich共济失调(FRDA)是核编码的frataxin基因突变的结果,该基因在线粒体中表达。有几条证据表明,frataxin参与了线粒体铁稳态。我们已经将frataxin基因转染到FRDA复合杂合子(FRDA-CH)的淋巴母细胞中,而frataxin表达不足,从而产生了FRDA-CH-t细胞,其中的信息和蛋白质被挽救到接近生理水平。 FRDA-CH细胞通过用游离铁,过氧化氢及其混合物进行攻击对氧化应激更加敏感,这与Fenton病理生理学化学机制一致,并且这种敏感性得以挽救以控制FRDA-CH-t细胞的水平。铁挑战导致FRDA-CH细胞中的线粒体铁水平增加,线粒体膜电位(MMP)降低,两者均在FRDA-CH-t细胞中得以挽救。 frataxin过表达挽救了低MMP和高线粒体铁浓度,表明这些细胞表型与FRDA的中心病理生理过程有关,而FRDA暴露于游离铁会加剧这一过程。但是,即使在生理性铁浓度下,FRDA-CH细胞的MMP降低,乌头酸酶和ICDH(两种支持MMP的酶)的活性也降低,并且可过滤的线粒体铁水平增加了一倍(但线粒体总铁量没有增加),并且观察到的表型在FRDA-CH-t细胞中被完全或部分拯救。众所周知,游离铁是有毒的。 frataxin缺乏症(直接或间接)引起可滤过的线粒体铁增加的发现,为这种疾病中细胞死亡的机制提供了新的假设,并可能成为治疗的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号